The voltage-gated K+ channel (Kv) pore forming a subunit, ERG1 (KCNH2), has
been identified as the locus of mutations in one type of inherited long QT
syndrome, LQT2. Heterologous expression of ERG1 reveals rapidly activating
and inactivating K+ currents, characterized by marked inward rectification
at potentials positive to 0 mV, which are similar to the rapid component o
f cardiac delayed rectification I-Kr. There are, however, marked difference
s in the properties of expressed ERG1 and endogenous cardiac I-Kr, suggesti
ng that functional I-Kr channels reflect the coassembly of full-length ERG1
with splice variants and/or accessory subunits. Consistent with these hypo
theses, N- and C-terminal variants of ERG1 have been identified, and it has
been demonstrated that heterologously expressed ERG1 and minK (or MiRP1) c
oimmunoprecipitate. Recent biochemical studies, however, suggest that only
full-length ERG1 is expressed in adult mouse, rat, or human heart. Clearly,
further studies, focused on identifying the subunits that coassemble with
ERG1 in vivo, as well as on post-translational processing of the full-lengt
h ERG1 protein will be necessary to define the molecular composition of fun
ctional cardiac I-Kr channels. (Trends Cardiovasc Med 2001; 11:286-294). (C
) 2001, Elsevier Science Inc.